Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cancer gene MYC shown to activate gene involved in metastasis

13.09.2005


Study points to importance of pathway in cancer progression



The cancer gene MYC is among the most commonly overexpressed oncogenes in human cancers. Most human cancers demonstrate high levels of MYC or its biological partners, including those of the breast, ovaries, lung, prostate, and skin, as well as leukemias and lymphomas. MYC is a regulator of other genes--a transcription factor--and scientists have been working for more than two decades to identify its target genes in order to understand how MYC causes so many cancers.

Now, scientists at The Wistar Institute have shown that MYC activates a gene called MTA1, which has been demonstrated by other researchers to regulate metastasis in a variety of cancers. While researchers have been exploring the possibility of blocking MTA1 to prevent metastasis, it was not previously known how MTA1 becomes activated in the first place. The study adds to the emerging picture of MYC’s role in cancer development and progression and identifies the pathway linking MYC and MTA1 as an area for further exploration into the genetics of metastasis. The study appears in Proceedings of the National Academy of Sciences and is available in the journal’s online "Early Edition."


"We and others have been working to understand what genes MYC turns on to cause malignant transformation," says Wistar associate professor Steven B. McMahon, Ph.D., senior author of the study. "Understanding metastasis is critical because patients rarely die of primary tumors--metastasis usually causes cancer deaths. Now, we have linked the well-known oncogene MYC to this target gene, MTA1, a key regulator of metastasis. Most importantly, if we block MYC’s ability to turn on MTA1, we block tumor formation. This is critical because it identifies a point in the metastasis pathway that can be targeted therapeutically."

Like the MYC cancer gene, MTA1 has been shown to play a role in a wide range of cancers, including breast and lung cancers and lymphomas. With the help of Wistar’s genomics facility headed by associate professor Louise C. Showe, Ph.D., McMahon and his colleagues sifted through nearly 10,000 genes before identifying MTA1 as a MYC target.

Among the pressing issues still to be resolved is understanding precisely why MYC’s activation of MTA1 leads to metastasis. In spite of the work still to be done, the first generation of drugs that inhibit MTA1 and its partners is already being developed, and McMahon’s study may inform this work. McMahon’s laboratory at Wistar continues to study other target genes of MYC in order to elucidate more fully how this oncogene acts in such a wide range of cancers.

Marion Wyce | EurekAlert!
Further information:
http://www.wistar.org

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

Im Focus: Bacteria harness the lotus effect to protect themselves

Biofilms: Researchers find the causes of water-repelling properties

Dental plaque and the viscous brown slime in drainpipes are two familiar examples of bacterial biofilms. Removing such bacterial depositions from surfaces is...

Im Focus: Hydrogen Bonds Directly Detected for the First Time

For the first time, scientists have succeeded in studying the strength of hydrogen bonds in a single molecule using an atomic force microscope. Researchers from the University of Basel’s Swiss Nanoscience Institute network have reported the results in the journal Science Advances.

Hydrogen is the most common element in the universe and is an integral part of almost all organic compounds. Molecules and sections of macromolecules are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

Innovation 4.0: Shaping a humane fourth industrial revolution

17.05.2017 | Event News

Media accreditation opens for historic year at European Health Forum Gastein

16.05.2017 | Event News

 
Latest News

New approach to revolutionize the production of molecular hydrogen

22.05.2017 | Materials Sciences

Scientists enlist engineered protein to battle the MERS virus

22.05.2017 | Life Sciences

Experts explain origins of topographic relief on Earth, Mars and Titan

22.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>